2024 ICD-10-CM Diagnosis Code A30.5

by

Lepromatous leprosy

  • A30.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM A30.5 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of A30.5 – other international versions of ICD-10 A30.5 may differ.

Applicable To

  • LL leprosy

The following code(s) above A30.5 contain annotation back-references

 that may be applicable to A30.5:

  • A00-B99  Certain infectious and parasitic diseases
  • A30  Leprosy [Hansen’s disease]

Approximate Synonyms

  • Lepromatous hansen’s disease (leprosy)

Clinical Information

  • A chronic communicable infection which is a principal or polar form of leprosy. This disorder is caused by mycobacterium leprae and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.

ICD-10-CM A30.5 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 867 Other infectious and parasitic diseases diagnoses with mcc
  • 868 Other infectious and parasitic diseases diagnoses with cc
  • 869 Other infectious and parasitic diseases diagnoses without cc/mcc

Convert A30.5 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to A30.5:

  • Leprosy
    • lepromatous A30.5 (diffuse) (infiltrated) (macular) (neuritic) (nodular)
    • LL A30.5
    • nodular A30.5